Replies to post #164210 on Cytodyn Inc (CYDY)

[MFGinvestor]

Fair, but it was a combined trial. We do not know the demand/ratio of critical or severe that was available. Maybe there were more critical that wanted to get in, but the design only allowed a specific amount. With them being separate, they can go as fast as the demand of critical/severe are available (that meets the trial criteria). Probably the reason they are separated.

However, do not disagree that cydy communication is not their strong suit.

[calstang66]

My understanding was that one of the trials would be criticals only.
However, IMO, waiting until August or October for the Brazil results don't seem to be where our focus should be right now. Our focus should be on the Philippines who are presently treating critical patients with leronlimab and there is nearly no wait for results. We will probably hear a lot about results Sunday on Philippines broadcast.